Fundraising FoxThe Capital Partnership — Full Portfolio
6 tracked investments · listed companies and verified rows first
Atia Vision develops OmniVu, a modular shape-changing dual-optic intraocular lens (IOL) that uses the eye's natural accommodative mechanism to restore near, intermediate, and distance vision for cataract patients.
BiotechHardwareHealthtechMedical DevicesCampbell, US
Henry Chen(Director)Claudio Argento(Director)Mariam Maghribi(Executive Officer, Director)Amr Salahieh(Director)Casey Gordon(Director)
Co-investorsAmed VenturesDelos CapitalRising TideShangBay Capital LLC
Supira Medical develops a next-generation percutaneous ventricular assist device (pVAD) to provide temporary mechanical circulatory support for high-risk patients undergoing coronary interventions and those in cardiogenic shock.
HardwareHealthtechMedical DevicesCampbell, US
Nitin Salunke(President & CEO)inJean Orth(Executive Officer)Mariam Maghribi(Executive Officer, Director)
BoardCasey Gordon(Director)Christopher Shen(Director)Bihua Chen(Director)
Co-investors415 CapitalAmed VenturesUnorthodox VenturesNovo HoldingsQatar Investment Authority
Laza Medical develops an AI- and robotics-powered ultrasound imaging system for structural heart, electrophysiology, and diagnostic cardiac procedures, combining real-time 3D heart modeling, procedural guidance, and robotic probe control.
AI & Machine LearningBiotechMedical DevicesRoboticsCampbell, US
Amr Salahieh(Executive Officer, Director, Promoter)Pablo Garcia Kilroy(General Manager)inCasey Gordon(Director)Mariam Maghribi(Executive Officer)David Voris(Executive Officer)
Co-investors415 CapitalPage One VenturesUnorthodox Ventures
BiotechCampbell, US
Amr Salahieh(Executive Officer, Director)Casey Gordon(Director)Mariam Maghribi(Executive Officer)
Co-investorsLAVLilly Asia Ventures
Rejuvenation develops proprietary mRNA and lipid nanoparticle technology to safely lengthen telomeres in human cells, targeting cellular aging and diseases caused by short telomeres including pulmonary fibrosis, liver disease, and bone marrow failure.
BiotechDeep TechHealthtechLongevitySan Francisco, US
Glenn Markov(Founder)inJohn Ramunas(Founder)inWill Olsen(Vice President Of Development)in
Co-investorsAsymmetry VenturesGold Dragon VenturesLifespan Vision VenturesStartupsStartXY Combinator+7 more
Other
Tracked investments with no reachable website or further public details — typically companies that wound down, renamed, or were absorbed.
Rows marked “SEC filing” are inferred from directors named on the company's SEC Form D — public regulatory data, not a portfolio list published by the firm.